Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in platelets
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 50 (3) , 365-376
- https://doi.org/10.1016/0049-3848(88)90266-6
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Two phasic generation of thromboxane a2 by the action of collagen on rat plateletsThrombosis Research, 1987
- Binding of a radioiodinated 13‐azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different speciesBritish Journal of Pharmacology, 1986
- Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548)Thrombosis Research, 1986
- Antagonism of platelet aggregation by 13-azaprostanoic acid in acute myocardial ischemia and sudden deathThrombosis Research, 1983
- The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human plateletsArchives of Biochemistry and Biophysics, 1982
- Accumulation of adenosine 3′, 5′-monophosphate induced by prostaglandin E1 binding to mastocytoma P-815 cellsBiochemical Pharmacology, 1981
- The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374) ? Equipotent to PGI2 in vitroNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Stimulation of human platelet adenylate cyclase by prostaglandin D2Thrombosis Research, 1974
- Inhibition of prostaglandin biosynthesisBiochemical Pharmacology, 1974